aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in Monmouth Junction, New Jersey, Tris Pharma is dedicated to innovating drug delivery technologies and developing medicines for disease treatment. The company's core mission is to enhance patient outcomes through advanced pharmaceutical solutions. Tris Pharma's product portfolio includes treatments for ADHD, pain management, and other central nervous system (CNS) disorders, focusing primarily on the U.S. market.
Notable figures affiliated with Tris Pharma include its leadership team and scientific advisors who bring extensive expertise in pharmaceuticals. The company has achieved significant milestones in drug development and delivery technology, contributing to improved therapeutic options for patients. Tris Pharma's impact is evident in its commitment to innovation and patient care, positioning it as a key player in the pharmaceutical industry.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Pharmaceuticals
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Tris Pharma founded?
Tris Pharma was founded in 2000.
Where is Tris Pharma’s headquarters located?
Tris Pharma’s headquarters is located in Monmouth Junction, NJ, US.
When was Tris Pharma’s last funding round?
Tris Pharma’s most recent funding round was for $16.6M (USD) in August 2023.
How many employees does Tris Pharma have?
Tris Pharma has 350 employees as of Feb 4, 2024.
How much has Tris Pharma raised to-date?
As of July 05, 2023, Tris Pharma has raised a total of $141.6M (USD) since Aug 28, 2023.
Add Comparison
Total Raised to Date
$141.6M
USD
Last Update Aug 28, 2023
Last Deal Details
$16.6M
USD
Aug 28, 2023
Grant
Total Employees Over Time
350
As of Feb 2024
Tris Pharma Address
2031 Us-130
Monmouth Junction,
New Jersey
08852
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts